Bioresorbable Vascular Scaffolds in a Real-World Patient Population-Results From a Mid-Term Angiographic Follow-Up

Saad, Mohammed (author): Umeå universitet,Kardiologi,Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.;Klinikum Bayreuth, Dept Cardiol, Bayreuth, Germany.;Univ Heart Ctr Lubeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Luebeck, Lubeck, Germany.

Abdin, Amr (author): Klinikum Bayreuth, Dept Cardiol, Bayreuth, Germany.;Univ Heart Ctr Lubeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Luebeck, Lubeck, Germany.

Thiele, Holger (author): Univ Heart Ctr Lubeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Luebeck, Lubeck, Germany.

Desch, Steffen (author): Univ Heart Ctr Lubeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Luebeck, Lubeck, Germany.

Ibrahimi, Pranvera (author): Umeå universitet,Kardiologi,Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.

Hoeher, Martin (author): Klinikum Bayreuth, Dept Cardiol, Bayreuth, Germany.

Henein, Michael (author): Umeå universitet,Kardiologi,Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.

(creator_code:org_t)

2016-06-21
2016
English.
In: Journal of Interventional Cardiology. - : Wiley. - 0896-4327 .- 1540-8183. ; 29:4, s. 341-347

Related links:: https://urn.kb.se/re...; show more...; https://doi.org/10.1...; https://urn.kb.se/re...; show less...

Abstract Subject headings

AIM: We aimed to investigate the safety and efficacy of bioresorbable vascular scaffolds (BVS) in daily use in a real-world patient population.METHODS AND RESULTS: Between March 2013 and September 2014, 224 patients (233 lesions) were treated with BVS at a tertiary care center. Patients underwent follow-up coronary angiography 3-6 months after implantation. Clinical presentations were stable angina in 101 patients (45.1%), unstable angina in 47 (21.0%), NSTEMI in 38 (17.0%), and STEMI in 38 (17.0%) patients. Twenty-two patients (27 lesions) had chronic total occlusion (CTO). Procedural success was achieved in all patients. Two patients died in the follow-up period due to BVS thrombosis (0.9%). In-hospital death occurred in further 3 patients (1.3%) due to other causes not related to the BVS implantation. Total BVS thrombosis was 3.1% (7 patients) and there was only 1 case of relevant restenosis on angiographic follow-up. The overall incidence of major adverse cardiac events was 11 (4.9%).CONCLUSIONS: Mid-term follow-up after implantation of BVS suggests a satisfactory safety profile and low restenosis rate in routine daily practice involving a large range of complex lesions.

By the author/editor: Saad, Mohammed; Abdin, Amr; Thiele, Holger; Desch, Steffen; Ibrahimi, Pranve ...; Wikström, Gerhar ...; show more...; Hoeher, Martin; Henein, Michael; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cardiac and Card ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.